Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.36 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | PPIA | P62937 | 2/20 | 0.33 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.33 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70001 | 0.72 | GPR3 (0.44) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL15182447 | 0.69 | POLB (0.37) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL8458737 | 0.69 | GPR3 (0.41) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL13185884 | 0.69 | GPR3 (0.41) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL6550865 | 0.69 | GPR3 (0.41) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL27804939 | 0.68 | GPR3 (0.37) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL851332 | 0.67 | HDAC3 (0.44) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL1215825 | 0.65 | HDAC3 (0.57) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL68634 | 0.65 | GPR3 (0.38) | GPR3HTR2AHDAC3HDAC4HDAC7 | |
| SCHEMBL216862 | 0.64 | MAOA (0.52) | GPR3HTR2AHDAC3HDAC4HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4486336-A2 | CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| WO-2024130218-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2023168066-A9 | OXIME-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE | CONAGEN INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024119140-A1 | CLEAVABLE COMONOMER STRATEGY FOR ACCELERATING REMOVAL OF GEL NAIL POLISH | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-06-06 | — | — | WO | disclosed |
| EP-4370503-A1 | ESTERS OF A RETINOID AND BAKUCHIOL AND PREPARATIONS THEREOF | Conagen Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-4367125-A1 | AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH | Alnylam Pharmaceuticals, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2024097746-A1 | ALKENE CYCLOPROPANATION WITH NICKEL CATALYST ENHANCER AND IMPROVED REARRANGEMENT REACTION | CONAGEN INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| EP-4359380-A1 | PROCESSES FOR THE PREPARATION OF (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL) METHYL)BENZYL) AMINO)ISOINDOLINE-1,3-DIONE | Celgene Corporation (US) | 2024-05-01 | — | — | EP | disclosed |
| WO-2024073745-A1 | INHIBITORS OF EGFR OR HER2 AND METHODS OF USE | ARBELLA THERAPEUTICS, LLC (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2023283434-A9 | AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2014210564-A1 | GLYCAN CONJUGATES AND USE THEREOF | ACADEMIA SINICA (TW) | 2014-12-31 | — | — | WO | disclosed |
| EP-2693879-A2 | MIGRASTATINS AND USES THEREOF | Sloan Kettering Institute For Cancer Research (US) | 2014-02-12 | — | — | EP | disclosed |
| EP-2550000-A1 | REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS | Rxi Pharmaceuticals Corporation (US) | 2013-01-30 | — | — | EP | disclosed |
| WO-2012139074-A2 | MIGRASTATINS AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-10-11 | — | — | WO | disclosed |
| EP-2432771-A1 | ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE | Infinity Pharmaceuticals, Inc. (US) | 2012-03-28 | — | — | EP | disclosed |
| WO-2011119852-A1 | REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS | RXI PHARMACEUTICALS CORPORATION (US) | 2011-09-29 | — | — | WO | disclosed |
| EP-2331018-A1 | ESOPHAGEAL VALVE | Vysera Biomedical Limited (IE) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010135360-A1 | ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE | INFINITY PHARMACEUTICALS, INC. (US) | 2010-11-25 | — | — | WO | disclosed |
| WO-2009153770-A1 | ESOPHAGEAL VALVE | VYSERA BIOMEDICAL LIMITED (IE) | 2009-12-23 | — | — | WO | disclosed |
| WO-2008119015-A2 | SYNTHESIS OF THIOHYDANTOINS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2008-10-02 | — | — | WO | disclosed |